Regional brain shrinkage over two years: Individual differences and effects of pro-inflammatory genetic polymorphisms
Introduction
Brain volume declines with age and significant shrinkage occurs in multiple gray and white matter regions within a relatively short time (Driscoll et al., 2009, Fjell et al., 2009, Fjell et al., 2013, Pfefferbaum et al., 1998, Raz et al., 2005, Raz et al., 2010, Raz et al., 2013, Resnick et al., 2003, Scahill et al., 2003). Notably, the magnitude and rate of volume reduction vary across brain regions. Shrinkage is especially pronounced in the cerebellum, tertiary association cortices, medial temporal lobe and neostriatum (Fjell et al., 2009, Raz et al., 2005, Tamnes et al., 2013), whereas primary visual cortex shows minimal age-related deterioration (Fjell et al., 2009, Raz et al., 2005, Raz et al., 2010). The rates of change vary, not only across brain regions, but also across individuals. Understanding individual differences in brain aging and elucidating their mechanisms have been hampered by the daunting number of proposed antecedents, and the cumulative record of the relevant studies remains sparse. Among multiple potential modifiers of the rate and extent of brain aging, vascular risk factors (Jagust, 2013, Raz and Rodrigue, 2006) and neuroinflammation (Finch, 2010, Godbout and Johnson, 2006) have attracted significant attention.
To date, several studies have attempted to gauge the influence of vascular risk (VR) and inflammation on regional brain volumes. Hypertension, a major and probably the most common VR, has been associated with shrinkage and smaller volume of age-sensitive brain regions, such as the hippocampus (Burns et al., 2012, Korf et al., 2004, Raz et al., 2005, Raz et al., 2007a, Raz et al., 2007b), and tertiary association cortices (Raz et al., 2003a, Raz et al., 2005, Raz et al., 2007a, Raz et al., 2007b).
Several biomarkers of inflammation have also been linked to individual differences in brain structure. Elevated circulating levels of pro-inflammatory cytokines (e.g., interleukin (IL)-6, and tumor necrosis factor α), C-reactive protein (CRP), and homocysteine (Hcy) correlate with reduced volumes of the hippocampus, cerebral cortex, and cerebral white matter, as well as increase in the volume of white matter hyperintensities (Bettcher et al., 2012, Choe et al., 2014, den Heijer et al., 2003, Jefferson et al., 2007, Marsland et al., 2008, Raz et al., 2012, Satizabal et al., 2012, Seshadri et al., 2008, Shimomura et al., 2011, Taki et al., 2013, Van Dijk et al., 2005, Williams et al., 2002, but see Feng et al., 2013, Morra et al., 2009, Scott et al., 2004).
In exploring the effects of pro-inflammatory biomarkers on the brain in humans, one must contend with two problems: the inability to manipulate the levels of biomarkers directly through induced inflammation, and the uncertain relationship between blood levels and brain content (Banks et al., 1995). For ethical reasons, blood levels of pro-inflammatory biomarkers cannot be safely manipulated in healthy humans, and there are doubts as to whether human IL-1β can cross the blood–brain barrier (Banks, 2005, Banks et al., 2001), although in rodents, chronic inflammation increases IL-1β gene expression in the hippocampus (Bardou et al., 2013). These challenges can be overcome, at least to some extent, by Mendelian randomization (Katan, 1986), which takes advantage of known genetic variants (single nucleotide polymorphisms; SNPs) that predispose individuals to various levels of the pro-inflammatory biomarkers in the brain and peripheral circulation. Thus, the study of persons with genetic polymorphisms that are associated with variable levels of a given risk factor may shed light on neuroinflammation in correlational studies. To date, several genetic variants associated with vascular health and inflammation have been linked to age-related and individual differences in brain volume and white matter integrity.
Several SNPs associated with various levels of proinflammatory response have been identified. Methylenetetrahydrofolate reductase (MTHFR C677T, rs1801133), a polymorphism of a gene that controls production of the enzyme necessary for metabolizing Hcy, modulates plasma concentration of Hcy (Bathum et al., 2007, de Lau et al., 2010). Variants in the IL-1β gene (e.g., IL-1β C-511T, rs16944) are associated with release of the eponymous cytokine in response to infection (Yarlagadda et al., 2009). Several SNPs that promote inflammation have been associated with structural brain differences. For instance, MTHFR C677T has been linked to smaller white matter volumes and accelerated shrinkage in periventricular fronto-parietal and parieto-occipital regions (Rajagopalan et al., 2011, Rajagopalan et al., 2012). G homozygotes of the polymorphism of the IL-6 gene (IL-6A-174G, rs1800795) have greater hippocampal gray matter volumes than heterozygotes and A homozygotes (Baune et al., 2012). In healthy adult carriers (Raz et al., 2012) the variant T alleles of IL-1β C-511T and CRP-286 C>A>T(rs3091244) polymorphisms are associated with increased burden of white matter hyperintensities (WMH). Notably, none of the extant studies of pro-inflammatory SNPs investigated their effect on rate of change.
Several other polymorphisms have been linked to individual differences in brain volumes and in the rate of age-related declines. The most prominent among these is a well-established genetic risk factor for late-onset Alzheimer's disease (AD; Roses, 1996), and the only consistently reported single-gene marker for longevity (Brooks-Wilson, 2013): the ε4 allele of the APOE gene. The APOE ε4 allele controls availability of the apolipoprotein E (APOE), a major factor in lipid transport. APOE ε4 has also been linked to increased risk of cardiovascular disease (Mahley & Rall, 2000) and hyperlipidemia (Davignon et al., 1988). However, the extant literature concerning the effect of APOE ε4 on brain aging and cognition is contradictory (Reinvang et al., 2013) and some suggest that positive findings may reflect inclusion of participants with incipient pathology (Cherbuin et al., 2007).
Reliance on cross-sectional comparison studies significantly impedes understanding of age-related change (see Raz & Kennedy, 2009 for a review). Although it has been made abundantly clear that cross-sectional studies cannot capture true dynamics of age-related change and the role of various mediators in shaping the age trajectories (e.g., Hofer and Sliwinski, 2001, Lindenberger and Pötter, 1998, Lindenberger et al., 2011, Maxwell and Cole, 2007), longitudinal studies remain relatively scarce. Moreover, a significant share of the extant literature on age-related brain shrinkage is focused solely on the mean change across individuals, without considering individual differences in change. This focus on a measure of central tendency, commonly expressed in a simple autoregressive or a residual regression model, precludes the understanding of differential aging. Whereas development of latent longitudinal methods, such as the latent change score model (LCSM; McArdle, 2008, McArdle, 2009, McArdle and Nesselroade, 1994), enables quantification of individual differences in age-related change, application of these methods is still relatively rare. With a few exceptions (McArdle et al., 2004, Raz et al., 2005, Raz et al., 2010, Raz et al., 2013), most of the extant longitudinal studies (e.g., Fjell et al., 2009, Pfefferbaum et al., 1998, Resnick et al., 2003) are limited to evaluation of mean change.
In this study, our aim was to address the limitations outlined above. First, we aimed to document regional brain changes occurring over two years in healthy adults and replicate previously reported findings. We expected, based on the extant literature, to observe mean shrinkage of the cerebellum, hippocampus, striatum, and prefrontal cortices, but no significant mean change in the volume of the primary visual cortex. Second, we examined individual variation in age-related change in regional brain volumes. Based on previous studies, we hypothesized to find significant variance (i.e., individual differences) in change across all regions of interest (ROIs). Third, we gauged the influence of putative modulators of brain aging trajectories on the rate of change in regional brain volumes. Specifically, we tested the effects of VR factors and biomarkers, such as arterial hypertension, and genetic variants associated with increased pro-inflammatory response, IL-1β C-511T, CRP-286 C>A>T, and MTHFR C677T. In addition, we evaluated the effect of a common genetic risk factor for AD (APOE ε4) on rates of change in regional brain volumes.
Section snippets
Participants
The data for this study were collected in a major metropolitan area in the USA. The participants were volunteers recruited through media advertisement and flyers. Persons who reported a history of cardiovascular, neurological or psychiatric disease, head trauma with loss of consciousness in excess of 5 min, thyroid dysfunction, diabetes mellitus, or history of treatment for drug and alcohol abuse or a habit of consuming three or more alcoholic drinks per day were excluded from the study.
Statistical analyses
Latent change score models were fitted to data from two measurement occasions separated by an average of 25 months. The LCSM simultaneously estimates cross-sectional individual differences, and individual differences in change (individual-level). On a conceptual level, latent change scores are analogous to traditional change scores estimated as the difference between follow-up and initial measurements. However, unlike raw change scores, latent change score estimates are free of measurement
Descriptive statistics
Descriptive statistics are presented in Table 1, Table 2. Prior to the analyses, we identified the potential outliers by Tukey upper and lower fences, multiplied by a factor of 2.2 (3Q (3rd quartile) + 2.2 × IQR (interquartile range), and 1Q − 2.2 × IQR; Hoaglin & Iglewicz, 1987). Three univariate outliers in the volumes of PFw, Hc, and Cd (one per ROI) were found. Upon exclusion of these observations (1.8% of the sample), all models were re-evaluated to assess the influence of the outliers on the
Discussion
In healthy adults, we found mild but significant mean shrinkage in 5 out of 10 examined brain regions over a period of about two years. More importantly, in all but one of these regions, we observed significant individual differences in shrinkage, a result that would have been missed by analytic approaches focusing solely on mean change. In some regions, the individual differences in shrinkage were explained in part by pro-inflammatory genetic variants, independent of cardiovascular risk
Acknowledgments
This research was supported by the National Institute on Aging grant R37 AG-11230 to NR. NP was supported by grants FOA11H-090, FOA13H-090, FO2011-0504 and FO2013-0189 from the Swedish Royal Academia of Sciences, Lars Hiertas Memorial Foundation, Solstickan Foundation and Department of Psychology at the Stockholm University (Ann-Charlotte Smedler, Head of the Department). We acknowledge Awantika Deshmukh's contribution to tracing of the ROIs.
Disclosure statement
There is no conflict of interest
References (119)
- et al.
Differential effects of duration and age on the consequences of neuroinflammation in the hippocampus
Neurobiol. Aging
(2013) Alzheimer's disease as homeostatic responses to age-related myelin breakdown
Neurobiol. Aging
(2011)- et al.
C-reactive protein is related to memory and medial temporal brain volume in older adults
Brain Behav. Immun.
(2012) - et al.
Region-specific reduction in brain volume in young adults with perinatal hypoxic–ischaemic encephalopathy
Eur. J. Paediatr. Neurol.
(2013) - et al.
Insulin is differentially related to cognitive decline and atrophy in Alzheimer's disease and aging
Biochim. Biophys. Acta
(2012) - et al.
Association of homocysteine with hippocampal volume independent of cerebral amyloid and vascular burden
Neurobiol. Aging
(2014) - et al.
Genetic variation in homocysteine metabolism, cognition, and white matter lesions
Neurobiol. Aging
(2010) - et al.
Age effects on atrophy rates of entorhinal cortex and hippocampus
Neurobiol. Aging
(2006) - et al.
Associations between elevated homocysteine, cognitive impairment, and reduced white matter volume in healthy old adults
Am. J. Geriatr. Psychiatr.
(2013) - et al.
Critical ages in the life course of the adult brain: nonlinear subcortical aging
Neurobiol. Aging
(2013)
“Mini-Mental State”: a practical method for grading the cognitive state of patients for the clinician
J. Psychiatr. Res.
Age and neuroinflammation: a lifetime of psychoneuroimmune consequences
Neurol. Clin.
Quantitative volumetric analyses of brain magnetic resonance imaging from rat with chronic neuroinflammation
Exp. Neurol.
Vulnerable neural systems and the borderland of brain aging and neurodegeneration
Neuron
Apolipoprotein E isoforms, serum cholesterol, and cancer
Lancet
A longitudinal study of brain morphometrics using quantitative magnetic resonance imaging and difference image analysis
NeuroImage
Purkinje cell loss in experimental autoimmune encephalomyelitis
NeuroImage
Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults
Biol. Psychiatry
Alzheimer's disease neuroimaging initiative. Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's disease neuroimaging initiative
Neurobiol. Aging
The assessment and analysis of handedness
Neuropsychologia
Hippocampal volumes differ across the mouse estrous cycle, can change within 24 hours, and associate with cognitive strategies
NeuroImage
Common folate gene variant, MTHFR C677T, is associated with brain structure in two independent cohorts of people with mild cognitive impairment
Neuroimage Clin.
Trajectories of brain aging in middle-aged and older adults: regional and individual differences
NeuroImage
Aging, sexual dimorphism, and hemispheric asymmetry of the cerebral cortex: replicability of regional differences in volume
Neurobiol. Aging
Differential aging of the brain: patterns, cognitive correlates and modifiers
Neurosci. Biobehav. Rev.
Differential age-related changes in the regional metencephalic volumes in humans: a five-year follow-up
Neurosci. Lett.
Differential brain shrinkage over six months shows limited association with cognitive practice
Brain Cogn.
Volume of white matter hyperintensities in healthy adults: contribution of age, vascular risk factors, and inflammation-related genetic variants
Biochim. Biophys. Acta
APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease
Neurosci. Biobehav. Rev.
Missing data
Sage University Papers Series on Quantitative Applications in the Social Sciences
Blood–brain barrier transport of cytokines: a mechanism for neuropathology
Curr. Pharm. Des.
Intravenous human interleukin alpha impairs memory processing in mice: dependence on blood–brain barrier transport into posterior division of the septum
J. Pharmacol. Exp. Ther.
Passage of cytokines across the blood–brain barrier
Neuroimmunomodulation
Genetic and environmental influences on plasma homocysteine: results from a Danish twin study
Clin. Chem.
Interleukin-6 gene (IL-6): a possible role in brain morphology in the healthy adult brain
J. Neuroinflammation
Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood
Arch. Gen. Psychiatry
The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease
Neuroscience
Genetics of healthy aging and longevity
Hum. Genet.
Alternate ways of assessing model fit
Neuroimaging and APOE genotype: a systematic qualitative review
Dement. Geriatr. Cogn. Disord.
Longitudinal changes of cortical thickness in early- versus late-onset Alzheimer's disease
Neurobiol. Aging
Relation of education to brain size in normal aging: implications for the reserve hypothesis
Neurology
A comparison of inclusive and restrictive strategies in modern missing-data procedures
Psychol. Methods
Normal brain development and aging: quantitative analysis at in vivo MR imaging in healthy volunteers
Radiology
How we should measure “change” — or should we?
Psychol. Bull.
Apolipoprotein E polymorphism and atherosclerosis
Arteriosclerosis
Homocysteine and brain atrophy on MRI of non-demented elderly
Brain
Longitudinal pattern of regional brain volume change differentiates normal aging from MCI
Neurology
Multiple comparisons among means
J. Am. Stat. Assoc.
An optimized method for estimating intracranial volume from magnetic resonance images
Magn. Reson. Med.
Cited by (42)
Hippocampal volume, and the anterior-posterior sub regions relates to recall and recognition over five years: Bidirectional brain-behaviour associations
2022, NeuroImageCitation Excerpt :The HC has long been the subject of study in neuroscience, and efforts to understand its functions continue apace. Although the HC shrinks with age (Persson et al., 2016a, 2014), it is unclear whether individuals also show substantial individual differences in volume reduction (Persson et al., 2016a, 2014; Gorbach et al., 2017). A recent literature review (Strange et al., 2014) showed that the anterior portion of the HC can be distinguished from the posterior section by sharp changes in functional characteristics.
Exercise and depression
2022, Exercise to Prevent and Manage Chronic Disease Across the LifespanInfluence of BDNF and MTHFR polymorphisms on hippocampal volume in first-episode psychosis
2020, Schizophrenia ResearchSpatial memory and navigation in ageing: A systematic review of MRI and fMRI studies in healthy participants
2019, Neuroscience and Biobehavioral Reviews